Hopewell Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 7

Hopewell Therapeutics General Information

Description

Developer of novel biodegradable lipid nanoparticles designed to give technology and services to bring genomic medicines to patients. The company's technology is developed through novel synthetic lipid-based nanoparticles for nucleic acid delivery for gene therapy and gene editing, enabling healthcare professionals to understand immunotherapy, gene therapy, and gene editing.

Contact Information

Website
www.hopewell-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 216 West Cummings Park
  • Woburn, MA 01801
  • United States
+1 (781)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, HealthTech, Life Sciences
Corporate Office
  • 216 West Cummings Park
  • Woburn, MA 01801
  • United States
+1 (781)

Hopewell Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hopewell Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 16-Sep-2025 $2.5M Completed Generating Revenue
5. Secondary Transaction - Private Completed Generating Revenue
4. Seed Round 17-May-2024 Completed Generating Revenue
3. Accelerator/Incubator Completed Startup
2. Seed Round 02-Feb-2022 $15.6M $15.6M Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Hopewell Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Hopewell Therapeutics Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Hopewell Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025165999-A1 Lipid nanoparticle for targeted delivery Pending 30-Jan-2024
WO-2025006613-A1 Lipid nanoparticles for cancer immunotherapy Inactive 27-Jun-2023
WO-2024206230-A1 Tissue targeting lipids and lipid nanoparticles Inactive 24-Mar-2023
WO-2024026026-A1 High throughput in vivo screening of lipid nanoparticles Inactive 27-Jul-2022
EP-4561537-A2 Lipid nanoparticles for immunotherapy Pending 27-Jul-2022 A61K9/0019
To view Hopewell Therapeutics’s complete patent history, request access »

Hopewell Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hopewell Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Checkmate Capital Venture Capital Minority
5Y Capital Venture Capital Minority
BOPU Capital Venture Capital Minority
Hike Capital Venture Capital Minority
IMO Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Hopewell Therapeutics FAQs

  • When was Hopewell Therapeutics founded?

    Hopewell Therapeutics was founded in 2018.

  • Where is Hopewell Therapeutics headquartered?

    Hopewell Therapeutics is headquartered in Woburn, MA.

  • What is the size of Hopewell Therapeutics?

    Hopewell Therapeutics has 19 total employees.

  • What industry is Hopewell Therapeutics in?

    Hopewell Therapeutics’s primary industry is Drug Delivery.

  • Is Hopewell Therapeutics a private or public company?

    Hopewell Therapeutics is a Private company.

  • What is Hopewell Therapeutics’s current revenue?

    The current revenue for Hopewell Therapeutics is .

  • How much funding has Hopewell Therapeutics raised over time?

    Hopewell Therapeutics has raised $25.9M.

  • Who are Hopewell Therapeutics’s investors?

    Checkmate Capital, 5Y Capital, BOPU Capital, Hike Capital, and IMO Ventures are 5 of 7 investors who have invested in Hopewell Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process